Save the Children partnership Partnerships Consumer Healthcare research Trials in people Information and tools for investors including share and dividend information, share price analysis, latest news and corporate reporting
Governance Board of Directors
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. Tweets from GSK.
Corporate reporting Our prescription medicines When you experience discomforts like sensitive teeth, colds and flu or joint pain, our everyday healthcare products are here to help you enjoy life to the full again.
You now have sucesfully register for the event and you can also access the latest updates, events and resources. Responsibility reports & data Smile Train partnership Our history
Comic Relief partnership
Our consumer healthcare products GlaxoSmithKline plc. You are currently visiting our global website. Science can improve health and well-being in so many ways, from the development of everyday healthcare products to medicines and vaccines.
Learn how our program can assist you if you need help paying for your GlaxoSmithKline prescription medicines and vaccines, whether you have coverage or not. We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare Image and video library Our use of animals Wellbutrin Glaxo used the help of PR firms and the appeal of lavish vacations to convince medical professionals to prescribe the antidepressant Wellbutrin for weight loss, sexual dysfunction, drug addiction and ADHD, even though the drug is FDA approved only to treat depression. Investors contact details Environment The homepage of the GSK global corporate website. Speeches & presentations Research and development Dosering Voksne >18 år: Anbefalt startdose: 150 mg 1 gang daglig. Corporate reporting
Our use of animals Warning against fraudulent internet recruitment activities Millions of people live with unmet healthcare needs. ©2020 GSK or licensor. Comic Relief partnership Trials in people
Responsible business is how we do business. GSK is not responsible for content on third-party websites.Take advantage of GSK product and disease state webinars to increase your medical knowledge.To report SUSPECTED ADVERSE REACTIONS, contact GSK at 1-888-825-5249 or FDA at 1-800-FDA-1088 or Trademarks are owned by or licensed to the GSK group of companies.This site is intended for US healthcare professionals only.
Save the Children partnership The company now expects the combined total of Other Operating Income and profit on disposal of interests in associates to be around £700 million in 2009.Cautionary statement regarding forward-looking statementsBrand names appearing in italics throughout this document are trademarks of GSK. Postgraduate opportunities "Under the terms of the agreement, GSK will transfer the US NDA and license the GSK expects to record a pre-tax gain of approximately £340 million in Other Operating Income as a result of this divestment. “This transaction is one of a series of actions we are taking to maximize the value of our current assets and to enable us to resource and invest in new products and upcoming launches. Development